Lv5
860 积分 2024-04-12 加入
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
17小时前
已完结
A Second-Generation Route to the Cereblon Fragment of ARV-471, Vepdegestrant
18小时前
已完结
New Ligand Development for Nickel-Catalyzed Reductive Cross-Coupling Enabling Practical Synthesis of SGLT-2 Inhibitors
18小时前
已完结
Chiral iodine-catalyzed asymmetric oxyamination of unactivated olefins
1天前
已完结
Route Development toward a Pyrazine Building Block to Enable Early Scale-Up Campaigns
3天前
已完结
Development and Optimization of a Scalable Palladium-Catalyzed C–N Coupling and Acid-Catalyzed Protecting Group Removal Telescope Process for the Synthesis of CDK2-Selective Candidate Tegtociclib (PF-07104091)
3天前
已完结
Development and Optimization of a Scalable Enzymatic Cascade-Carbamate Formation Telescope Process for the Synthesis of CDK2 Selective Candidate Tegtociclib (PF-07104091)
2个月前
已完结
Cu-Catalyzed C–N Couplings with Benzilamide Ligands
2个月前
已完结
Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease
3个月前
已完结
Room-Temperature Cu-Catalyzed Amination of Aryl Bromides Enabled by DFT-Guided Ligand Design
3个月前
已完结
皖公网安备34019202002308
